Skin Cancer Information Center
Skin cancer is the most commonly diagnosed cancer in the United States, with more than one million new diagnoses each year. The most common types of skin cancer are basal cell carcinoma and squamous cell carcinoma. Melanoma is a less common form of skin cancer, but tends to be more aggressive.
Exposure to ultraviolet radiation increases the risk of skin cancer, and sun protection plays an important role in skin cancer prevention. Once skin cancer occurs, it is important to detect and treat it as early as possible in order to obtain the best outcomes.
Advances in surgery and other local treatments for skin cancer have improved treatment effectiveness and cosmetic outcomes. In addition, researchers continue to evaluate new approaches to systemic (whole-body) therapy for melanoma.
Understanding skin cancer treatment options, the role of different doctors specializing in the treatment of skin cancer, and how and when to access new and innovative skin cancer treatment options available through clinical trials is essential in order to achieve the best outcome from skin cancer treatment.
The Cancer Consultants Skin Cancer Information Center has been designed to help patients understand options for skin cancer prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of skin cancer.
Headline Skin Cancer News 
Erivedge Approved for Basal Cell Skin Cancer
May provide benefit for patients with advanced disease.
Increased Skin Cancer Risk Among Those with Inflammatory Bowel Disease
Treatment with thiopurines may increase skin cancer risk.
CancerConnect Live Web Chat with Dr. Barrie Cassileth from Memorial Sloan-Kettering Cancer Center on Complementary Cancer Therapies on Thursday, November 17th at 6PM EST
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service;...
Skin Cancer Tips
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Preparing for Surgery You can help ensure that your surgery and recovery go smoothly and that you have...
Know the Signs of Depression in Cancer Patients Because a significant number of cancer patients—an estimated 25 percent—experience...
Skin Cancer Management
Inspiration, Hope & Resources
The Skin Cancer Foundation By Diana Price When Dr. Perry Robbins founded the Skin Cancer Foundation in 1979,...
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Skin Cancer Clinical Trials
REFMAL31 – A STUDY TO DETERMINE THE BIOEQUIVALENCE OF AN ORAL FORMULATION OF TOPOTECAN CONTAINING THE DRUG SUBSTANCE MANUFACTURED BY NEW PROCESS RELATIVE TO THE CURRENT STUDY FORMULATION OF TOPOTECAN IN PATIENTS WITH ADVANCED SOLID TUMORS
REFMAL32 – AN OPEN-LABEL, SAFETY, PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF MULTIPLE DOSES OF GW572016 TO EXAMINE THE INHIBITION OF EGFR/ERBB-2 PHOSPHORYLATION IN CANCER PATIENTS WITH SOLID TUMORS
REFMAL33 – A PHASE I TRIAL OF WEEKLY AMONAFIDE (AMF)IN PATIENTS WITH ADVANCED, SOLID TUMORS
 |
 |
 |
 |
